2012 annual financial data

Eloxx Pharmaceuticals 2012 Net margin

Eloxx Pharmaceuticals 2012 net margin with verified reported values.

Direct answer

Net margin was -2,533.07%.

Operating income was -5,090,391 USD and net income was -5,066,133 USD.
Operating cash flow was -4,386,049 USD.

Get free Eloxx Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
200,000 USD
Operating income
-5,090,391 USD
Net income
-5,066,133 USD
Operating cash flow
-4,386,049 USD